(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1320026 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of LRRC8D mRNA CTD PMID:22079256 1,2-dimethylhydrazine multiple interactions ISO RGD:1320027 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LRRC8D mRNA CTD PMID:22206623 1,2-dimethylhydrazine decreases expression ISO RGD:1320027 6480464 1, 2-Dimethylhydrazine results in decreased expression of LRRC8D mRNA CTD PMID:22206623 1,4-dichlorobenzene increases expression ISO RGD:1320027 6480464 4-dichlorobenzene results in increased expression of LRRC8D mRNA CTD PMID:26975756 17beta-estradiol multiple interactions ISO RGD:1320026 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of LRRC8D mRNA, [Progesterone co-treated with Estradiol] results in decreased expression of LRRC8D mRNA CTD PMID:17404688 , PMID:30165855 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1320027 6480464 Tetrachlorodibenzodioxin results in increased expression of LRRC8D mRNA CTD PMID:19933214 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of LRRC8D mRNA CTD PMID:33387578 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1320027 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of LRRC8D mRNA CTD PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1320026 6480464 Tetrachlorodibenzodioxin results in decreased expression of LRRC8D mRNA CTD PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1320027 6480464 Tetrachlorodibenzodioxin affects the expression of LRRC8D mRNA CTD PMID:21570461 2,4-diaminotoluene increases expression ISO RGD:1320027 6480464 2, 4-diaminotoluene results in increased expression of LRRC8D mRNA CTD PMID:20713471 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of LRRC8D mRNA CTD PMID:21346803 3-methylcholanthrene increases expression ISO RGD:1320027 6480464 Methylcholanthrene results in increased expression of LRRC8D mRNA CTD PMID:20713471 4,4'-sulfonyldiphenol increases methylation ISO RGD:1320027 6480464 bis(4-hydroxyphenyl)sulfone results in increased methylation of LRRC8D exon CTD PMID:33297965 4,4'-sulfonyldiphenol affects methylation ISO RGD:1320027 6480464 bis(4-hydroxyphenyl)sulfone affects the methylation of LRRC8D gene CTD PMID:31683443 4-hydroxyphenyl retinamide decreases expression ISO RGD:1320027 6480464 Fenretinide results in decreased expression of LRRC8D mRNA CTD PMID:28973697 acrylamide increases expression ISO RGD:1320026 6480464 Acrylamide results in increased expression of LRRC8D mRNA CTD PMID:32763439 aflatoxin B1 increases methylation ISO RGD:1320026 6480464 Aflatoxin B1 results in increased methylation of LRRC8D intron CTD PMID:30157460 all-trans-retinoic acid decreases expression ISO RGD:1320026 6480464 Tretinoin results in decreased expression of LRRC8D mRNA CTD PMID:33167477 antirheumatic drug decreases expression ISO RGD:1320026 6480464 Antirheumatic Agents results in decreased expression of LRRC8D mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO RGD:1320026 6480464 aristolochic acid I results in decreased expression of LRRC8D mRNA CTD PMID:33212167 avobenzone decreases expression ISO RGD:1320026 6480464 avobenzone results in decreased expression of LRRC8D mRNA CTD PMID:31016361 benzo[a]pyrene increases expression ISO RGD:1320027 6480464 Benzo(a)pyrene results in increased expression of LRRC8D mRNA CTD PMID:20713471 benzo[a]pyrene decreases methylation ISO RGD:1320026 6480464 Benzo(a)pyrene results in decreased methylation of LRRC8D 3' UTR, Benzo(a)pyrene results in decreased methylation of LRRC8D exon CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:1320026 6480464 Benzo(a)pyrene affects the methylation of LRRC8D 5' UTR CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:1320027 6480464 Benzo(a)pyrene results in decreased expression of LRRC8D mRNA CTD PMID:19770486 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1320026 6480464 7 more ... CTD PMID:19150397 , PMID:20382639 benzo[e]pyrene increases methylation ISO RGD:1320026 6480464 benzo(e)pyrene results in increased methylation of LRRC8D intron CTD PMID:30157460 bisphenol A decreases expression ISO RGD:1320026 6480464 bisphenol A results in decreased expression of LRRC8D mRNA CTD PMID:29275510 bisphenol A multiple interactions ISO RGD:1320026 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of LRRC8D gene CTD PMID:31601247 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of LRRC8D mRNA CTD PMID:34947998 bisphenol A decreases methylation ISO RGD:1320026 6480464 bisphenol A results in decreased methylation of LRRC8D gene CTD PMID:31601247 cadmium dichloride decreases methylation EXP 6480464 Cadmium Chloride results in decreased methylation of LRRC8D promoter CTD PMID:22457795 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of LRRC8D mRNA CTD PMID:33453195 chlorpyrifos decreases expression ISO RGD:1320027 6480464 Chlorpyrifos results in decreased expression of LRRC8D mRNA CTD PMID:32715474 choline multiple interactions ISO RGD:1320027 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of LRRC8D gene CTD PMID:20938992 cobalt dichloride decreases expression ISO RGD:1320026 6480464 cobaltous chloride results in decreased expression of LRRC8D mRNA CTD PMID:19320972 crocidolite asbestos decreases expression ISO RGD:1320026 6480464 Asbestos, Crocidolite results in decreased expression of LRRC8D mRNA CTD PMID:25351596 cyclosporin A increases expression ISO RGD:1320026 6480464 Cyclosporine results in increased expression of LRRC8D mRNA CTD PMID:20106945 , PMID:25562108 diazinon increases methylation ISO RGD:1320026 6480464 Diazinon results in increased methylation of LRRC8D gene CTD PMID:22964155 dibutyl phthalate decreases expression ISO RGD:1320027 6480464 Dibutyl Phthalate results in decreased expression of LRRC8D mRNA CTD PMID:21266533 dioxygen increases expression ISO RGD:1320027 6480464 Oxygen deficiency results in increased expression of LRRC8D mRNA CTD PMID:24205000 dioxygen affects methylation ISO RGD:1320027 6480464 Oxygen deficiency affects the methylation of LRRC8D promoter CTD PMID:24205000 doxorubicin decreases expression ISO RGD:1320026 6480464 Doxorubicin results in decreased expression of LRRC8D mRNA CTD PMID:29803840 epoxiconazole decreases expression ISO RGD:1320027 6480464 epoxiconazole results in decreased expression of LRRC8D mRNA CTD PMID:35436446 ethanol affects expression ISO RGD:1320027 6480464 Ethanol affects the expression of LRRC8D mRNA CTD PMID:30319688 fenthion decreases expression ISO RGD:1320027 6480464 Fenthion results in decreased expression of LRRC8D mRNA CTD PMID:34813904 fipronil decreases expression EXP 6480464 fipronil results in decreased expression of LRRC8D mRNA CTD PMID:34044035 fluoranthene multiple interactions ISO RGD:1320027 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of LRRC8D mRNA CTD PMID:28329830 flutamide increases expression EXP 6480464 Flutamide results in increased expression of LRRC8D mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:1320027 6480464 [1 more ... CTD PMID:20938992 , PMID:22206623 fulvestrant multiple interactions ISO RGD:1320026 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of LRRC8D gene CTD PMID:31601247 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of LRRC8D mRNA CTD PMID:24136188 hypochlorous acid increases expression ISO RGD:1320027 6480464 Hypochlorous Acid results in increased expression of LRRC8D mRNA CTD PMID:19376150 L-methionine multiple interactions ISO RGD:1320027 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of LRRC8D gene CTD PMID:20938992 leflunomide increases expression ISO RGD:1320026 6480464 leflunomide results in increased expression of LRRC8D mRNA CTD PMID:28988120 methapyrilene increases methylation ISO RGD:1320026 6480464 Methapyrilene results in increased methylation of LRRC8D intron CTD PMID:30157460 methidathion increases expression ISO RGD:1320027 6480464 methidathion results in increased expression of LRRC8D mRNA CTD PMID:34813904 methyl methanesulfonate decreases expression ISO RGD:1320026 6480464 Methyl Methanesulfonate results in decreased expression of LRRC8D mRNA CTD PMID:23649840 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of LRRC8D mRNA CTD PMID:25729387 paracetamol affects expression ISO RGD:1320027 6480464 Acetaminophen affects the expression of LRRC8D mRNA CTD PMID:17562736 paracetamol decreases expression ISO RGD:1320026 6480464 Acetaminophen results in decreased expression of LRRC8D mRNA CTD PMID:22230336 perfluorononanoic acid increases expression ISO RGD:1320026 6480464 perfluoro-n-nonanoic acid results in increased expression of LRRC8D mRNA CTD PMID:32588087 phenobarbital increases expression ISO RGD:1320027 6480464 Phenobarbital results in increased expression of LRRC8D mRNA CTD PMID:19270015 pirinixic acid multiple interactions ISO RGD:1320026 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of LRRC8D mRNA CTD PMID:19710929 potassium chromate decreases expression ISO RGD:1320026 6480464 potassium chromate(VI) results in decreased expression of LRRC8D mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:1320026 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of LRRC8D mRNA CTD PMID:22079256 progesterone multiple interactions ISO RGD:1320026 6480464 [Progesterone co-treated with Estradiol] results in decreased expression of LRRC8D mRNA CTD PMID:17404688 prothioconazole increases expression ISO RGD:1320026 6480464 prothioconazole results in increased expression of LRRC8D mRNA CTD PMID:35048155 quercetin decreases expression ISO RGD:1320026 6480464 Quercetin results in decreased expression of LRRC8D mRNA CTD PMID:21632981 resorcinol decreases expression ISO RGD:1320026 6480464 resorcinol results in decreased expression of LRRC8D mRNA CTD PMID:22623647 rotenone decreases expression ISO RGD:1320026 6480464 Rotenone results in decreased expression of LRRC8D mRNA CTD PMID:32178731 silicon dioxide decreases expression ISO RGD:1320026 6480464 Silicon Dioxide results in decreased expression of LRRC8D mRNA CTD PMID:25351596 sunitinib increases expression ISO RGD:1320026 6480464 Sunitinib results in increased expression of LRRC8D mRNA CTD PMID:31533062 temozolomide increases expression ISO RGD:1320026 6480464 Temozolomide results in increased expression of LRRC8D mRNA CTD PMID:31758290 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of LRRC8D mRNA CTD PMID:34492290 titanium dioxide increases expression ISO RGD:1320027 6480464 titanium dioxide results in increased expression of LRRC8D mRNA CTD PMID:23557971 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of LRRC8D mRNA CTD PMID:25729387 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of LRRC8D mRNA CTD PMID:25729387 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of LRRC8D mRNA CTD PMID:33387578 tungsten decreases expression ISO RGD:1320027 6480464 Tungsten results in decreased expression of LRRC8D mRNA CTD PMID:30912803 tunicamycin increases expression ISO RGD:1320026 6480464 Tunicamycin results in increased expression of LRRC8D mRNA CTD PMID:29453283 valproic acid affects expression ISO RGD:1320027 6480464 Valproic Acid affects the expression of LRRC8D mRNA CTD PMID:17963808 valproic acid decreases expression ISO RGD:1320027 6480464 Valproic Acid results in decreased expression of LRRC8D mRNA CTD PMID:19136453 valproic acid affects expression ISO RGD:1320026 6480464 Valproic Acid affects the expression of LRRC8D mRNA CTD PMID:25979313